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Conclusions. Received data might indicate the availability of mediated nephroprotective and cardioprotective effects of 
fenofibrate in addition to it’s direct effect on decreasing triglycerides and high density cholesterol.  
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Actuality. At present, great importance is attached to the problem of comorbidity. There is a high incidence of combined 
pathology – osteoarthritis (OA) and type 2 diabetes mellitus (T2DM), especially in the older age group. At the same time, 
there are many studies that focus on the development of OA on the background of disorders of bone metabolism.  
Purpose. To determine the level of vitamin D in patients with OA and with the combination of OA and T2DM and its 
effect on the course of OA.  
Materials and methods. In total, 50 patients were examined at rheumatology and endocrinology departments in the 
Kharkiv Regional Clinical Hospital. All patients were divided into 2 groups. Group 1 - 20 patients with OA, group 2 - 20 
patients with combined course of OA and T2DM. The mean age of the patients was 56.08±0.71. The survey plan 
included anthropometric data, global knee pain [visual analog scale (VAS)], the Western Ontario and McMaster 
Universities Osteoarthritis Index (WOMAC), C-reactive protein (CRP). All patients with OA were made X-ray examination 
of knees. Determination of vitamin D level was done by ECLIA.  
Results. We determined statistically significant association of the degree of functional insufficiency of the joints with 
increasing of complexity of diagnosis (p<0,05). Thus, the indices of WOMAC Pain score and WOMAC stiffness were 
similar in both groups, but the indices of WOMAC physical function subscore were significantly higher in patients with 
combined course of OA and T2DM (p<0.05). The level of vitamin D was statistically significant less patients with isolated 
OA (29.055.18) compared to the group of patients with comorbid pathology (36.25.21, p<0.05). We didn`t find any 
statistically significant correlations between the level of vitamin D and radiological changes and the indices of WOMAC in 
patients with isolated OA. In 2nd group of patients we determined moderate statistically significant negative correlations 
between the level of vitamin D and WOMAC stiffness (r=-0.41; p<0.05) and WOMAC physical function subscore (r=-0.51; 
p<0.05). We level of CRP in 2nd group was higher (14,611,99) compared to the group of patients (11,41,79), but this 
difference wasn`t significant. We determined moderate negative significant correlation between the level of CRP and the 
level of vitamin D in both groups of patients (r=-0.43; p<0.05, r=-0.35; p<0.05 respectively).  
Conclusions. The study indicates that changes in bone metabolism are observed in groups of patient with OA and the 
combined course of OA and T2DM, in particular a significant decrease in vitamin D. A reliable association of vitamin D 
with the WOMAC index indicates a possible effect of bone metabolism disorders on the progression of OA in patients 
with comorbid pathology.  
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Rationale. Type 2 diabetes occurs when our body becomes resistant to insulin and pancreas produce more insulin to 
compensate and later pancreas becomes decompensated. Type 2 diabetes is major risk factor for cardiovascular 
disease.  
Purpose. was to determine the effect of interleukin-1β (IL-1β) and resistin to development of cardiomyopathy (CMP) in 
patients with diabetes mellitus (DM) type-2. 
Materials and methods. Our work is part of study of the Department of Internal Medicine and Endocrinology № 3 
Kharkiv National Medical University (Diabetes mellitus and co-morbid pathology). An analysis of the survey data was 
performed with 102 patients with type 2 diabetes with disease duration from 1 to 9 years. Depending on the degree of 
CMP, patients were divided into groups: group 1 (n = 38) - with moderate CMP expression, significant distribution factor 
was body mass index (BMI) of less than 28.5 kg/m², group 2 ( n = 64) - with severe CMP expression and BMI of more 
than 28.5 kg/m². The control group consisted of 20 healthy individuals.  
The levels of resistin and IL-1β in serum was determined by ELISA according to standard instructions. Statistical analysis 
of the results was carried out Statistica 7.0. 
Results. The levels of IL-1β (pg/ml) in the blood serum of patients with DM type 2 of the 1st and 2nd groups (11,34 ± 
0,25 and 14.76 ± 0.28 respectively) were higher (p <0 .05) compared to the control group (8,12 ± 0,24). Resistin levels in 
patients of the 2nd group (13,19 ± 0,18, ng/ml) was significantly higher than in patients of the 1st group (10,51 ± 0,25, 
ng/ml, p <0.05 ) and control group (10,06 ± 0,35, ng/ml, p <0.05). significant correlations was found between the levels of 
IL-1β and resistin in patients of the group 1 (R = +0,589, p = 0,00010), and patients in group 2 (R = + 0,450, p = 
0,00019). 
Conclusions. The levels of IL-1β and resistin were significantly higher in patients with severe cardiomyopathy. The 
presence of relationship between Resistin and IL-1β can demonstrate the interaction and influence on the formation of 
diabetic myocardial damage of these cytokines.  
Thus in patients with type 2 diabetes with a BMI of more than 28.5 kg/m2 and increased levels of pro-inflammatory IL-1β 
and resistin is an additional risk factor for the formation of diabetic CMP, which is a precursor to heart failure.  
 
 
 
